Sanofi CEO pledges disciplined M&A, silent on Genzyme

PARIS - Sanofi-Aventis(SASY.PA) Chief Executive Chris Viehbacher pledged on Thursday to remain disciplined on mergers and acquisitions and stayed silent on plans to buy U.S. biotech Genzyme(GENZ.O).

read more

 

Please choose:

 RSS Feed | more news

International News